"L'Institut Sainte-Catherine est un établissement de santé privé d’intérêt collectif en Avignon spécialisé dans le dépistage et le traitement des cancers. Il est doté de 88 lits d’hospitalisation, 38 places d’hôpital de jour."

During the past decade, Institut Sainte Catherine conducted 124 clinical trials. In the 10-year time frame, 124 clinical trials started and 22 clinical trials were completed, i.e. on average, 17.7% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 18 clinical trials were completed. i.e. 27.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Sainte Catherine" #1 sponsor was "UNICANCER" with 38 trials, followed by "ARCAGY/ GINECO GROUP" with 15 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 15 trials sponsored, "Hoffmann-La Roche" with 12 trials sponsored and "Centre Leon Berard" with 12 trials sponsored. Other sponsors include 100 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Sainte Catherine" #1 collaborator was "AstraZeneca" with 12 trials as a collaborator, "National Cancer Institute, France" with 7 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator and "Pfizer" with 5 trials as a collaborator. Other collaborators include 129 different institutions and companies that were collaborators in the rest 112 trials.

According to Clinical.Site data, the most researched conditions in "Institut Sainte Catherine" are "Breast Cancer" (30 trials), "Colorectal Cancer" (9 trials), "Prostate Cancer" (9 trials), "Ovarian Cancer" (8 trials) and "Metastatic Breast Cancer" (7 trials). Many other conditions were trialed in "Institut Sainte Catherine" in a lesser frequency.

Most popular intervention types in "Institut Sainte Catherine" are "Drug" (158 trials), "Radiation" (28 trials), "Other" (21 trials), "Procedure" (19 trials) and "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Paclitaxel" (13 trials), "fluorouracil" (12 trials), "radiation therapy" (11 trials) and "Capecitabine" (10 trials). Other intervention names were less common.

The vast majority of trials in "Institut Sainte Catherine" are 131 trials for "All" genders, 45 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are NaN active trials in "Institut Sainte Catherine". 2 are not yet recruiting, 49 are recruiting, 41 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 72 completed trials in Institut Sainte Catherine, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Sainte Catherine, 3 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 88 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 18 trials that are defined as “Not Applicable".

Institut Sainte Catherine has several departments that took part in Clinical trials: "Institut Sainte-Catherine; Oncologie" - 2 trials